What are the recommended usage and dosage standards for Alpelisib?

Alpelisib (Alpelisib) is a selective PI3Kα inhibitor, mainly used to treat certain types of breast cancer, especially those with PIK Patients with 3CAmutated hormone receptor-positive (HR+) and HER2-negative advanced breast cancer. In order to obtain the best efficacy, patients should strictly follow the medication plan prescribed by the doctor when using Apelvis, and reasonably arrange the dosage and medication time.

The recommended standard usage of Apelvis is usually 300 mg once daily, administered in tablet form. This dose is mostly suitable for adult patients. The medication should be taken at a fixed time, and it is recommended to take it with food. It is best to take it immediately after a meal to increase the drug absorption rate and reduce gastrointestinal discomfort. If the patient has severe adverse reactions or abnormal kidney or liver function, the doctor may adjust the dose to 250mg or 200mg based on individual circumstances.

Patients need to closely monitor blood sugar levels and skin reactions while taking the medication. Apelvis may cause side effects such as hyperglycemia and rash. Therefore, fasting blood sugar, hemoglobin A1c and other indicators need to be checked regularly before taking the drug and during treatment, and use hypoglycemic drugs when necessary. In addition, patients with a history of skin allergies should use it with caution and gradually observe tolerance under the guidance of a doctor.

If the patient misses a dose, it should be taken as soon as possible that day, but if it is close to the next dose time, the missed dose should be skipped to avoid doubling. At the same time, it is prohibited to stop the medication or increase or decrease the dose without authorization, so as not to affect the therapeutic effect. It is recommended that patients maintain communication with their doctors throughout the entire medication process and conduct regular follow-up visits to adjust treatment strategies based on individual responses to achieve the best treatment results.

Reference materials:https://www.drugs.com/